Invention Grant
US09403846B2 Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
有权
碳环和杂环取代的六氢吡喃并[3,4-d] [1,3]噻嗪-2-胺化合物
![Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds](/docs/US/2016-08-02/US09403846B2/abs.jpg.600x600.jpg)
- Patent Title: Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
- Patent Title (中): 碳环和杂环取代的六氢吡喃并[3,4-d] [1,3]噻嗪-2-胺化合物
-
Application No.: US14653549Application Date: 2013-12-04
-
Publication No.: US09403846B2Publication Date: 2016-08-02
- Inventor: Michael Aaron Brodney , Brian Thomas O'Neill , Christopher Ryan Butler , Erik Alphie LaChapelle
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent John A. Wichtowski
- International Application: PCT/IB2013/060633 WO 20131204
- International Announcement: WO2014/097038 WO 20140626
- Main IPC: C07D513/04
- IPC: C07D513/04
![Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds](/abs-image/US/2016/08/02/US09403846B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides compounds of formula I, wherein the variables R1, R2, R5 and b are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Public/Granted literature
- US20160002264A1 Carbocyclic- And Heterocyclic-Substituted Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds Public/Granted day:2016-01-07
Information query
